Literature DB >> 28498932

From CNTNAP2 to Early Expressive Language in Infancy: The Mediation Role of Rapid Auditory Processing.

Valentina Riva1, Chiara Cantiani1, April A Benasich2, Massimo Molteni1, Caterina Piazza3, Roberto Giorda4, Ginette Dionne5, Cecilia Marino1,6.   

Abstract

Although it is clear that early language acquisition can be a target of CNTNAP2, the pathway between gene and language is still largely unknown. This research focused on the mediation role of rapid auditory processing (RAP). We tested RAP at 6 months of age by the use of event-related potentials, as a mediator between common variants of the CNTNAP2 gene (rs7794745 and rs2710102) and 20-month-old language outcome in a prospective longitudinal study of 96 Italian infants. The mediation model examines the hypothesis that language outcome is explained by a sequence of effects involving RAP and CNTNAP2. The ability to discriminate spectrotemporally complex auditory frequency changes at 6 months of age mediates the contribution of rs2710102 to expressive vocabulary at 20 months. The indirect effect revealed that rs2710102 C/C was associated with lower P3 amplitude in the right hemisphere, which, in turn, predicted poorer expressive vocabulary at 20 months of age. These findings add to a growing body of literature implicating RAP as a viable marker in genetic studies of language development. The results demonstrate a potential developmental cascade of effects, whereby CNTNAP2 drives RAP functioning that, in turn, contributes to early expressive outcome.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 28498932     DOI: 10.1093/cercor/bhx115

Source DB:  PubMed          Journal:  Cereb Cortex        ISSN: 1047-3211            Impact factor:   5.357


  7 in total

1.  Neuroimaging genetics studies of specific reading disability and developmental language disorder: A review.

Authors:  Nicole Landi; Meaghan Perdue
Journal:  Lang Linguist Compass       Date:  2019-09-05

2.  Effect of feeding mode on infant growth and cognitive function: study protocol of the Chilean infant Nutrition randomized controlled Trial (ChiNuT).

Authors:  Rosario Toro-Campos; Cecilia Algarín; Patricio Peirano; Marcela Peña; Teresa Murguia-Peniche; Steven S Wu; Ricardo Uauy
Journal:  BMC Pediatr       Date:  2020-05-18       Impact factor: 2.125

3.  Reduced left-lateralized pattern of event-related EEG oscillations in infants at familial risk for language and learning impairment.

Authors:  Chiara Cantiani; Silvia Ortiz-Mantilla; Valentina Riva; Caterina Piazza; Roberta Bettoni; Gabriella Musacchia; Massimo Molteni; Cecilia Marino; April A Benasich
Journal:  Neuroimage Clin       Date:  2019-03-12       Impact factor: 4.881

4.  Common variant of CNTNAP2 gene modulate the social performances and functional connectivity of posterior right temporoparietal junction.

Authors:  Tongjian Bai; Long Zhang; Xiaohui Xie; Guixian Xiao; Wanling Huang; Dandan Li; Meidan Zu; Lin Wei; Xianbo Zuo; Gong-Jun J I; Panpan Hu; Chunyan Zhu; Bensheng Qiu; Yanghua Tian; Kai Wang
Journal:  Soc Cogn Affect Neurosci       Date:  2019-12-30       Impact factor: 3.436

5.  Paternal-but Not Maternal-Autistic Traits Predict Frontal EEG Alpha Asymmetry in Infants with Later Symptoms of Autism.

Authors:  Valentina Riva; Cecilia Marino; Caterina Piazza; Elena M Riboldi; Giulia Mornati; Massimo Molteni; Chiara Cantiani
Journal:  Brain Sci       Date:  2019-11-26

6.  A common variant of CNTNAP2 is associated with sub-threshold autistic traits and intellectual disability.

Authors:  Yuka Shiota; Tetsu Hirosawa; Yuko Yoshimura; Sanae Tanaka; Chiaki Hasegawa; Sumie Iwasaki; Kyung-Min An; Daiki Soma; Masuhiko Sano; Shigeru Yokoyama; Mitsuru Kikuchi
Journal:  PLoS One       Date:  2021-12-13       Impact factor: 3.240

7.  Distinct ERP profiles for auditory processing in infants at-risk for autism and language impairment.

Authors:  Valentina Riva; Chiara Cantiani; Giulia Mornati; Martina Gallo; Laura Villa; Elisa Mani; Irene Saviozzi; Cecilia Marino; Massimo Molteni
Journal:  Sci Rep       Date:  2018-01-15       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.